Table 2 |
|||
|
CD105 immunohistochemical localization in primary salivary gland tumors (IMD = intratumoral microvessel density) [14]. |
|||
|
CD105 positivity |
|||
|
|
|||
|
Type and metastatic status |
N |
Frequency |
IMD (mean ± SD) |
|
|
|||
|
Adenoid cystic carcinoma |
|||
|
Primary, non-metastasizing |
41 |
2.4% |
0 |
|
Primary, metastasizing |
10 |
30.0% |
0.7 (± 1.3) |
|
Polymorphous low-grade adenocarcinoma |
|||
|
Primary, non-metastasizing |
17 |
47.1% |
1.6 (± 2.0) |
|
Primary, metastasizing |
2 |
0 |
0 |
|
Mucoepidermoid carcinoma |
|||
|
Primary, non-metastasizing |
36 |
83.3% |
4.8 (± 6.0) |
|
Primary, metastasizing |
4 |
100% |
6.2 (± 2.1) |
|
|
|||
|
Cardoso et al. BMC Cancer 2009 9:391 doi:10.1186/1471-2407-9-391 |
|||
